Influence of drug load and physical form of cinnarizine in new SNEDDS dosing regimens: in vivo and in vitro evaluations

Research output: Contribution to journalJournal article

Standard

Influence of drug load and physical form of cinnarizine in new SNEDDS dosing regimens : in vivo and in vitro evaluations. / Siqueira, Scheyla D V S; Müllertz, Anette; Gräeser, Kirsten; Kasten, Georgia; Mu, Huiling; Rades, Thomas.

In: A A P S Journal, Vol. 19, No. 2, 03.2017, p. 587-594.

Research output: Contribution to journalJournal article

Harvard

Siqueira, SDVS, Müllertz, A, Gräeser, K, Kasten, G, Mu, H & Rades, T 2017, 'Influence of drug load and physical form of cinnarizine in new SNEDDS dosing regimens: in vivo and in vitro evaluations', A A P S Journal, vol. 19, no. 2, pp. 587-594. https://doi.org/10.1208/s12248-016-0038-4

APA

Siqueira, S. D. V. S., Müllertz, A., Gräeser, K., Kasten, G., Mu, H., & Rades, T. (2017). Influence of drug load and physical form of cinnarizine in new SNEDDS dosing regimens: in vivo and in vitro evaluations. A A P S Journal, 19(2), 587-594. https://doi.org/10.1208/s12248-016-0038-4

Vancouver

Siqueira SDVS, Müllertz A, Gräeser K, Kasten G, Mu H, Rades T. Influence of drug load and physical form of cinnarizine in new SNEDDS dosing regimens: in vivo and in vitro evaluations. A A P S Journal. 2017 Mar;19(2):587-594. https://doi.org/10.1208/s12248-016-0038-4

Author

Siqueira, Scheyla D V S ; Müllertz, Anette ; Gräeser, Kirsten ; Kasten, Georgia ; Mu, Huiling ; Rades, Thomas. / Influence of drug load and physical form of cinnarizine in new SNEDDS dosing regimens : in vivo and in vitro evaluations. In: A A P S Journal. 2017 ; Vol. 19, No. 2. pp. 587-594.

Bibtex

@article{c665797ac955411fa04944309d4d96e7,
title = "Influence of drug load and physical form of cinnarizine in new SNEDDS dosing regimens: in vivo and in vitro evaluations",
abstract = "The aim of this work was to evaluate the influence of drug load and physical form of cinnarizine (CIN) in self-nanoemulsifying drug delivery systems (SNEDDS) on absorption in rats. Further, the predictivity of the dynamic in vitro lipolysis model was evaluated. The following dosing regimens were assessed: (1) CIN dissolved in SNEDDS at 80{\%} of equilibrium solubility (Seq) (SNEDDS 80{\%}); (2) supersaturated SNEDDS with CIN dissolved at 200{\%} Seq (super-SNEDDS solution); (3) SNEDDS suspension with CIN added at 200{\%} Seq (CIN partially dissolved and partially suspended) (super-SNEDDS suspension); (4) drug-free SNEDDS co-dosed with aqueous CIN suspension (Chasing principle), and (5) CIN aqueous suspension. The CIN dose was kept constant for all dosing regimens. Therefore, the super-SNEDDS solution and super-SNEDDS suspension contained 2.5-fold less SNEDDS pre-concentrate than SNEDDS 80{\%} and the Chasing principle. In vivo, a higher AUC after dosing CIN in SNEDDS 80{\%} and the Chasing principle was obtained when compared to the super-SNEDDS solution, super-SNEDDS suspension, and aqueous suspension. In vitro, a higher extent of CIN in the aqueous phase was observed for all SNEDDS-containing dosing regimens, compared to the aqueous suspension. Since the drug level in the aqueous phase is traditionally considered as the fraction available for absorption, a lack of in vitro-in vivo relation was observed. This study revealed that the physical form of CIN in the current SNEDDS does not affect CIN absorption and solubilization, whereas the drug load, or amount of co-dosed lipid, significantly influenced CIN bioavailability.",
keywords = "Journal Article",
author = "Siqueira, {Scheyla D V S} and Anette M{\"u}llertz and Kirsten Gr{\"a}eser and Georgia Kasten and Huiling Mu and Thomas Rades",
year = "2017",
month = "3",
doi = "10.1208/s12248-016-0038-4",
language = "English",
volume = "19",
pages = "587--594",
journal = "A A P S Journal",
issn = "1550-7416",
publisher = "Springer",
number = "2",

}

RIS

TY - JOUR

T1 - Influence of drug load and physical form of cinnarizine in new SNEDDS dosing regimens

T2 - in vivo and in vitro evaluations

AU - Siqueira, Scheyla D V S

AU - Müllertz, Anette

AU - Gräeser, Kirsten

AU - Kasten, Georgia

AU - Mu, Huiling

AU - Rades, Thomas

PY - 2017/3

Y1 - 2017/3

N2 - The aim of this work was to evaluate the influence of drug load and physical form of cinnarizine (CIN) in self-nanoemulsifying drug delivery systems (SNEDDS) on absorption in rats. Further, the predictivity of the dynamic in vitro lipolysis model was evaluated. The following dosing regimens were assessed: (1) CIN dissolved in SNEDDS at 80% of equilibrium solubility (Seq) (SNEDDS 80%); (2) supersaturated SNEDDS with CIN dissolved at 200% Seq (super-SNEDDS solution); (3) SNEDDS suspension with CIN added at 200% Seq (CIN partially dissolved and partially suspended) (super-SNEDDS suspension); (4) drug-free SNEDDS co-dosed with aqueous CIN suspension (Chasing principle), and (5) CIN aqueous suspension. The CIN dose was kept constant for all dosing regimens. Therefore, the super-SNEDDS solution and super-SNEDDS suspension contained 2.5-fold less SNEDDS pre-concentrate than SNEDDS 80% and the Chasing principle. In vivo, a higher AUC after dosing CIN in SNEDDS 80% and the Chasing principle was obtained when compared to the super-SNEDDS solution, super-SNEDDS suspension, and aqueous suspension. In vitro, a higher extent of CIN in the aqueous phase was observed for all SNEDDS-containing dosing regimens, compared to the aqueous suspension. Since the drug level in the aqueous phase is traditionally considered as the fraction available for absorption, a lack of in vitro-in vivo relation was observed. This study revealed that the physical form of CIN in the current SNEDDS does not affect CIN absorption and solubilization, whereas the drug load, or amount of co-dosed lipid, significantly influenced CIN bioavailability.

AB - The aim of this work was to evaluate the influence of drug load and physical form of cinnarizine (CIN) in self-nanoemulsifying drug delivery systems (SNEDDS) on absorption in rats. Further, the predictivity of the dynamic in vitro lipolysis model was evaluated. The following dosing regimens were assessed: (1) CIN dissolved in SNEDDS at 80% of equilibrium solubility (Seq) (SNEDDS 80%); (2) supersaturated SNEDDS with CIN dissolved at 200% Seq (super-SNEDDS solution); (3) SNEDDS suspension with CIN added at 200% Seq (CIN partially dissolved and partially suspended) (super-SNEDDS suspension); (4) drug-free SNEDDS co-dosed with aqueous CIN suspension (Chasing principle), and (5) CIN aqueous suspension. The CIN dose was kept constant for all dosing regimens. Therefore, the super-SNEDDS solution and super-SNEDDS suspension contained 2.5-fold less SNEDDS pre-concentrate than SNEDDS 80% and the Chasing principle. In vivo, a higher AUC after dosing CIN in SNEDDS 80% and the Chasing principle was obtained when compared to the super-SNEDDS solution, super-SNEDDS suspension, and aqueous suspension. In vitro, a higher extent of CIN in the aqueous phase was observed for all SNEDDS-containing dosing regimens, compared to the aqueous suspension. Since the drug level in the aqueous phase is traditionally considered as the fraction available for absorption, a lack of in vitro-in vivo relation was observed. This study revealed that the physical form of CIN in the current SNEDDS does not affect CIN absorption and solubilization, whereas the drug load, or amount of co-dosed lipid, significantly influenced CIN bioavailability.

KW - Journal Article

U2 - 10.1208/s12248-016-0038-4

DO - 10.1208/s12248-016-0038-4

M3 - Journal article

C2 - 28070714

VL - 19

SP - 587

EP - 594

JO - A A P S Journal

JF - A A P S Journal

SN - 1550-7416

IS - 2

ER -

ID: 185745439